27 Einträge gefunden

1. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
2. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

   1. Marx, Andreas
   2. Schumann, Aljoscha
   3. Höflmayer, Doris
   4. Bady, Elena
   5. Hube-Magg, Claudia
   6. Möller, Katharina
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
3. Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

   1. Marx, Andreas
   2. Luebke, Andreas M
   3. Clauditz, Till S
   4. Steurer, Stefan
   5. Fraune, Christoph
   6. Hube-Magg, Claudia
   7. Büscheck, Franziska

   2020 - Forschungsinformationssystem des UKE
4. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
5. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

   1. Kind, Simon
   2. Büscheck, Franziska
   3. Höflmayer, Doris
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Tsourlakis, Maria Christina
   7. Steurer, Stefan

   2020 - Forschungsinformationssystem des UKE
6. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
7. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

   1. Minner, Sarah
   2. Hager, Dominik
   3. Steurer, Stefan
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Möller-Koop, Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
8. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

   1. Steurer, Stefan
   2. Hager, Benjamin
   3. Büscheck, Franziska
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Minner, Sarah
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
9. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
10. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

    1. Weidemann, Sören A
    2. Sauer, Charlotte
    3. Luebke, Andreas M
    4. Möller-Koop, Christina
    5. Steurer, Stefan
    6. Hube-Magg, Claudia
    7. Büscheck, Franziska

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
11. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    1. Eichenauer, Till
    2. Hussein, Mohammad
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Büscheck, Franziska
    6. Höflmayer, Doris
    7. Tsourlakis, Maria Christina

    2019 - Forschungsinformationssystem des UKE
12. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    1. Steurer, Stefan
    2. Schwemmer, Lara
    3. Hube-Magg, Claudia
    4. Büscheck, Franziska
    5. Höflmayer, Doris
    6. Tsourlakis, Maria Christina
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE
13. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    1. Heumann, Asmus
    2. Heinemann, Nina
    3. Hube-Magg, Claudia
    4. Lang, Dagmar S
    5. Grupp, Katharina
    6. Kluth, Martina
    7. Minner, Sarah

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
14. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

    1. Wilczak, Waldemar
    2. Rashed, Semin
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Simon, Ronald
    6. Büscheck, Franziska
    7. Clauditz, Till Sebastian

    2017 - Forschungsinformationssystem des UKE
15. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    1. Tsourlakis, Maria Christina
    2. Eleftheriadou, Agapi
    3. Stender, Annegret
    4. Weigand, Philipp
    5. Grupp, Katharina
    6. Hube-Magg, Claudia
    7. Kluth, Martina

    2017 - Forschungsinformationssystem des UKE
16. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

    1. Melling, Nathaniel
    2. Taskin, B
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Minner, Sarah
    6. Koop, Christina
    7. Grob, Tobias

    2016 - Forschungsinformationssystem des UKE
17. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

    1. Burdelski, Christoph
    2. Kleinhans, Sandra
    3. Kluth, Martina
    4. Hube-Magg, Claudia
    5. Minner, Sarah
    6. Koop, Christina
    7. Graefen, Markus

    2016 - Forschungsinformationssystem des UKE
18. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

    1. Pust, Alexandra
    2. Kylies, Dominik
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Minner, Sarah
    6. Koop, Christina
    7. Grob, Tobias

    2016 - Forschungsinformationssystem des UKE
19. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    1. Burdelski, Christoph
    2. Menan, Devi
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
20. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

    1. Grupp, Katharina
    2. Roettger, Laura
    3. Kluth, Martina
    4. Hube-Magg, Claudia
    5. Simon, Ronald
    6. Lebok, Patrick
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE